Get more information on DNA Synthesis Market - Request Sample Report
The DNA Synthesis Market was valued at USD 3.59 billion in 2023 and is expected to reach USD 15.48 billion by 2032, growing at a CAGR of 17.66% over the forecast period 2024-2032.
The DNA synthesis market is accelerating significantly due to its expanding applications in molecular biology, genetic engineering, and clinical diagnostics. With the increasing demand for drug discovery and personalized medicine, DNA synthesis has become crucial in understanding of genetic underpinnings of diseases, precise diagnostics, and support of targeted treatment approaches. DNA synthesis is crucial in mapping tumor genomes, identifying mutations, and guiding targeted therapies in cancer genomics, which highlights its role in precision medicine.
Furthermore, synthetic biology has fueled the demand for DNA synthesis as it facilitates the design and construction of biological components and systems. CRISPR-Cas9 technologies rely on custom gene synthesis to synthesize therapeutic genes and their gene editing tools, which typifies the growing role of synthetic DNA in gene therapy and genome editing. A strategic program like the Precision Medicine Initiative coupled with companion diagnostics is fueling the applications of gene expression studies, thus rapidly increasing the demand for synthetic DNA probes and primers.
Regulatory changes affect market trends as countries update genetic research policies to encourage innovation in medicine and healthcare. The dynamic regulatory scenario has removed restrictions on genetic studies and created a research-friendly and drug-therapy-appropriate environment. Industry players are responding to these trends by expanding product portfolios and launching advanced gene synthesis services that meet the increasing demands in the market. For instance, GenScript launched GMP double-strand and single-strand services in 2022 to support cell and gene therapy. The company's 2023 GenTitan Gene Fragments service improves synthesis cost-effectiveness.
Strategic collaborations and mergers also fuel the market growth because they are trying to leverage the added expertise in diagnostics and therapeutics. Companies such as Twist Bioscience are innovating through partnerships, for example, partnering with Astellas Pharma in 2023 for immunotherapy research. Regional expansions also work as the accelerating factor for market growth in which access to biotechnology is one of the primary reasons. For example, NunaBio received USD 2.4 million in funding in 2023 to take their synthetic DNA production to the next step and underpin the growth of access to DNA synthesis technologies across various fields of science. Continuous improvements in technologies related to molecular separation and protein purification also contribute to faster, cost-effective solutions across applications in medicine, diagnostics, and academic research.
Drivers
Rising Demand for DNA Synthesis Products & Services Across Multiple Applications Drives Market Growth
The demand for synthetic DNA is surging, greatly influencing advancements in enzyme production, novel protein synthesis, and new drug discoveries. The integration of synthetic biology in drug development and innovative treatment options has further boosted the need for synthetic DNA, prompting the creation of technologies that offer enhanced DNA purity, increased yield, and reduced production costs. This demand has shifted commercial priorities from natural DNA isolation to synthetic DNA production. The growing prevalence of chronic diseases and increasing awareness of personalized treatment options have further driven global demand for synthetic DNA products and services. For instance, data from the American Cancer Society in 2024 projected around 2,001,140 new cancer cases in the U.S., underscoring the need for precise diagnostic methods, thereby increasing the adoption of synthetic DNA services. Additionally, approvals of gene-based therapies for rare diseases are accelerating market growth. In December 2023, the FDA approved Casgevy and Lyfgenia as the first cell-based gene therapies for sickle cell disease, with Casgevy utilizing advanced genome editing technology. Such regulatory endorsements and innovative launches are major contributors to market expansion.
Enhanced Healthcare Spending and Support for Precision Medicine Propels Market Expansion
With rising healthcare costs, there is an increasing demand from providers and patients for precision medicine, alongside investments in R&D for new treatments. Gene synthesis, which facilitates tailored treatments for complex diseases, such as cancer and genetic disorders, is becoming a key component in clinical research and therapeutic interventions. Government support for precision medicine and drug innovation also fuels market growth. For example, the U.K. Department for Business and Trade announced in 2021 a public spending increase of USD 27.36 billion for R&D, focusing on precision medicine, with 2.4% of the GDP earmarked for research by 2027. These initiatives aim to make advanced treatments more accessible and cost-effective, promoting market expansion. Moreover, increased fundraising by industry leaders for investments in advanced technology and modern facilities further propels market growth, enhancing the availability of advanced DNA synthesis solutions.
Restraints
Regulatory Uncertainty Delays Product Launches
Shortage of Skilled Workforce in Synthetic Biology
By Service
The oligonucleotide synthesis segment was the dominant segment in 2023, driven strongly by a focus on genomics research, personalized medicine, and the exploration of mechanisms of genetic diseases. Oligonucleotides are very important for molecular biology, genetics, and genomics applications, such as PCR, DNA sequencing, and gene expression studies. Greater recognition of genetic disorders has also increased demand for oligonucleotides, both in diagnostics and therapeutic applications. For example, in August 2023, UC San Diego launched a Gene Therapy Initiative, supported by a USD 5 million gift from the Nancy and Geoffrey Stack Foundation, that aims to develop new treatments for rare genetic diseases that afflict both children and adults.
The gene synthesis segment is expected to have the highest CAGR of 16.7% in the forecast period. This segment includes custom gene synthesis and gene library synthesis. Gene synthesis supports gene therapy approaches, introducing new genes into cells to treat or prevent diseases. Other techniques include manipulation of the mutated genes through selective reverse mutation, repair of damaged genes, or substitution of mutated genes with functional ones. Also, gene synthesis allows the cloning of synthetic therapeutic genes to custom viral vectors, optimizing expression and improving specificity in gene delivery.
By Application
In 2023, the research and development segment accounted for the dominant share of the market at 63.3%, primarily due to the growing demand for DNA synthesis in global research projects. Oligonucleotides are fundamental reagents in molecular biology research genetic testing and drug discovery. DNA synthesis is highly important in many R&D areas such as biopharmaceuticals, synthetic biology, gene synthesis, and genome editing. Additionally, the market growth has significantly increased with the rapid acceptance of CRISPR technology. Scientists have been using CRISPR for a wide array of applications including gene knockout studies and therapeutic interventions that encourage industrial growth.
Therapeutics is the fastest-growing segment and offers the highest CAGR at 16.41% over the forecast period. DNA synthesis has always supported research in therapeutics across geographies continuously with the capability to synthesize DNA rapidly and with great accuracy, which allows for effective profiling of quite diverse targets: synthesizing whole synthetic gene circuits as well as creating and screening therapeutic enzymes, among others. The requirement of customized treatment of different genetic disorders as well as cancers has brought the sector of therapeutics in front of DNA synthesis applications.
North America was a dominant region in the DNA synthesis market in 2023, accounting for 39.7% of revenue due to high public awareness, well-developed healthcare facilities, and high investments in R&D. High incidence of chronic diseases and strong research efforts on gene synthesis and therapy are additional factors driving growth in this region. In the US market, demand for synthetic DNA and RNA is increasing in research, diagnostics, and therapeutics. Competitive landscape factors include the established players as well as new entrants.
Europe has a lot of potential due to government support, good research infrastructure, and increasing gene therapy practice. The UK has good prospects in growth and related areas because of strong genetic research, government initiatives, and health infrastructure; one example that features a mark of progress in gene editing is the approval for CRISPR-based Casgevy. It has a good R&D environment and government support for biotechnology, thus offering scope for expansion. On the other hand, the demand for DNA synthesis in France is propelled by research into cancer and cardiovascular diseases. The potential applications of oligonucleotides in diagnostics and personalized treatments are critical to its growth.
The Asia Pacific region is anticipated to experience the fastest growth during this period, a CAGR of 17.5% from 2024 to 2032, resulting from the high demand for synthetic DNA in research and diagnostics. China leads with a forecasted 21.4% CAGR, fueled by the growth of CROs and facility expansions, like GenScript's in Jiangsu. Japan's aging population and focus on personalized medicine contribute to market growth, while India’s high birth rate and genetic disorder prevalence, alongside government initiatives, foster a promising environment for DNA synthesis.
Do You Need any Customization Research on DNA Synthesis Market - Enquire Now
Key Players
Thermo Fisher Scientific Inc. - DNA synthesis reagents and oligonucleotide synthesis services
Twist Bioscience Corporation - Synthetic DNA and oligonucleotide pools
BIONEER CORPORATION - Custom gene synthesis and oligonucleotides
Eton Bioscience, Inc. - DNA sequencing and synthesis services
LGC Biosearch Technologies - Oligonucleotide synthesis and nucleic acid synthesis solutions
IBA Lifesciences GmbH - Custom DNA and RNA oligonucleotide synthesis
Eurofins Scientific - Genomics services including gene synthesis and oligonucleotide production
Integrated DNA Technologies, Inc. - DNA and RNA oligonucleotides, gene synthesis, and CRISPR solutions
Quintara Biosciences - Gene synthesis and molecular biology services
GenScript Biotech Corporation - Gene synthesis, plasmid preparation, and peptide synthesis
Biomatik - Custom gene synthesis, protein production, and molecular biology reagents
Kaneka Eurogentec S.A. - DNA synthesis and custom oligonucleotide production
OriGene Technologies, Inc. - Custom gene synthesis and molecular cloning services
ProMab Biotechnologies, Inc. - Gene synthesis and antibody production
ProteoGenix - Gene synthesis and antibody production for synthetic biology applications
Synbio Technologies - Custom gene synthesis and synthetic biology solutions
Recent Development
In May 2024, Molecular Assemblies, Inc. debuted a Partnering Program that will license its Full Enzymatic Synthesis (FES) technology to select partners. Through the program, the company's automated synthesis platform, alongside any enhancements to the FES technology, will be made available, along with necessary licenses to support in-house research applications.
In November 2023, QIAGEN reported that it had entered into a strategic collaboration with Element Biosciences, Inc. to offer combined NGS workflows compatible with the AVITI System, Element's next-generation sequencing platform.
Eurofins BioPharma Product Testing (Eurofins Scientific) greatly expanded its Stability Services in April 2023 at its facility in Lancaster, PA, an expansion expected to drive demand for DNA synthesis production.
TECAN partnered with Element Biosciences in February 2023, with the company then offering a benchtop NGS solution that now also comprises the MagicPrep NGS, along with an innovative DNA sequencing platform called the AVITI System, developed by Element Biosciences.
| Report Attributes | Details |
|---|---|
| Market Size in 2023 | USD 3.59 Billion |
| Market Size by 2032 | USD 15.48 Billion |
| CAGR | CAGR of 17.66% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | • By Service (Oligonucleotide Synthesis, Custom Oligonucleotide Synthesis, Pre-designed Oligonucleotide Synthesis, Gene Synthesis) • By Application (Research and Development, Therapeutics, Diagnostic) • By End-User (Biopharmaceutical Companies, Academic and Research Institutes, Contract Research Organizations) |
| Regional Analysis/Coverage | North America (US, Canada, Mexico), Europe (Eastern Europe [Poland, Romania, Hungary, Turkey, Rest of Eastern Europe] Western Europe] Germany, France, UK, Italy, Spain, Netherlands, Switzerland, Austria, Rest of Western Europe]), Asia Pacific (China, India, Japan, South Korea, Vietnam, Singapore, Australia, Rest of Asia Pacific), Middle East & Africa (Middle East [UAE, Egypt, Saudi Arabia, Qatar, Rest of Middle East], Africa [Nigeria, South Africa, Rest of Africa], Latin America (Brazil, Argentina, Colombia, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific Inc., Twist Bioscience Corporation, BIONEER CORPORATION, Eton Bioscience, Inc, LGC Biosearch Technologies, IBA Lifesciences GmbH, Eurofins Scientific, Integrated DNA Technologies, Inc., Quintara Biosciences, GenScript Biotech Corporation, Biomatik, Kaneka Eurogentec S.A., OriGene Technologies, Inc., ProMab Biotechnologies, Inc., ProteoGenix, Synbio Technologies, and Others |
| Key Drivers | • Rising Demand for DNA Synthesis Products & Services Across Multiple Applications • Enhanced Healthcare Spending and Support for Precision Medicine |
| RESTRAINTS | • Regulatory Uncertainty Delays Product Launches • Shortage of Skilled Workforce in Synthetic Biology |
Ans: DNA Synthesis Market size was valued at USD 3.59 billion in 2023.
Ans: DNA Synthesis Market is anticipated to expand by 17.66% from 2024 to 2032.
Ans: North America held a significant market share of around 39.7% in 2023.
Ans: USD 15.48 billion is expected to growth of DNA Synthesis Market by 2032.
Ans: Risk of accidental release of synthetic DNA or the creation of dangerous pathogens.
Table of Contents:
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence of Genetic Disorders (2023)
5.2 Application Trends in DNA Synthesis (2023), by Region
5.3 Device Volume and DNA Synthesis Production, by Region (2020-2032)
5.4 Research and Healthcare Spending, by Region (2023)
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new Product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. DNA Synthesis Market Segmentation, by Service
7.1 Chapter Overview
7.2 Oligonucleotide Synthesis
7.2.1 Oligonucleotide Synthesis Market Trends Analysis (2020-2032)
7.2.2 Oligonucleotide Synthesis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Custom Oligonucleotide Synthesis
7.3.1 Custom Oligonucleotide Synthesis Market Trends Analysis (2020-2032)
7.3.2 Custom Oligonucleotide Synthesis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Pre-designed Oligonucleotide Synthesis
7.4.1 Pre-designed Oligonucleotide Synthesis Market Trends Analysis (2020-2032)
7.4.2 Pre-designed Oligonucleotide Synthesis Market Size Estimates and Forecasts to 2032 (USD Billion)
7.5 Gene Synthesis
7.5.1 Gene Synthesis Market Trends Analysis (2020-2032)
7.5.2 Gene Synthesis Market Size Estimates and Forecasts to 2032 (USD Billion)
8. DNA Synthesis Market Segmentation, by Application
8.1 Chapter Overview
8.2 Research and Development
8.2.1 Research and Development Market Trends Analysis (2020-2032)
8.2.2 Research and Development Market Size Estimates and Forecasts to 2032 (USD Million)
8.3 Therapeutics
8.3.1 Therapeutics Market Trends Analysis (2020-2032)
8.3.2 Therapeutics Market Size Estimates and Forecasts to 2032 (USD Million)
8.4 Diagnostic
8.4.1 Diagnostic Market Trends Analysis (2020-2032)
8.4.2 Diagnostic Market Size Estimates and Forecasts to 2032 (USD Million)
9. DNA Synthesis Market Segmentation, by End-User
9.1 Chapter Overview
9.2 Biopharmaceutical Companies
9.2.1 Biopharmaceutical Companies Market Trends Analysis (2020-2032)
9.2.2 Biopharmaceutical Companies Market Size Estimates and Forecasts to 2032 (USD Million)
9.3 Academic and Research Institutes
9.3.1 Academic and Research Institutes Market Trends Analysis (2020-2032)
9.3.2 Academic and Research Institutes Market Size Estimates and Forecasts to 2032 (USD Million)
9.4 Contract Research Organizations
9.4.1 Contract Research Organizations Market Trends Analysis (2020-2032)
9.4.2 Contract Research Organizations Market Size Estimates and Forecasts to 2032 (USD Million)
10. Regional Analysis
10.1 Chapter Overview
10.2 North America
10.2.1 Trends Analysis
10.2.2 North America DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.2.3 North America DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.2.4 North America DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.5 North America DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.2.6 USA
10.2.6.1 USA DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.2.6.2 USA DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.6.3 USA DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.2.7 Canada
10.2.7.1 Canada DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.2.7.2 Canada DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.7.3 Canada DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.2.8 Mexico
10.2.8.1 Mexico DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.2.8.2 Mexico DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.2.8.3 Mexico DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3 Europe
10.3.1 Eastern Europe
10.3.1.1 Trends Analysis
10.3.1.2 Eastern Europe DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.1.3 Eastern Europe DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.4 Eastern Europe DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.5 Eastern Europe DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.1.6 Poland
10.3.1.6.1 Poland DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.6.2 Poland DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.6.3 Poland DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.1.7 Romania
10.3.1.7.1 Romania DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.7.2 Romania DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.7.3 Romania DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.1.8 Hungary
10.3.1.8.1 Hungary DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.8.2 Hungary DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.8.3 Hungary DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.1.9 turkey
10.3.1.9.1 Turkey DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.9.2 Turkey DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.9.3 Turkey DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.1.10 Rest of Eastern Europe
10.3.1.10.1 Rest of Eastern Europe DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.1.10.2 Rest of Eastern Europe DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.1.10.3 Rest of Eastern Europe DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2 Western Europe
10.3.2.1 Trends Analysis
10.3.2.2 Western Europe DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.3.2.3 Western Europe DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.4 Western Europe DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.5 Western Europe DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.6 Germany
10.3.2.6.1 Germany DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.6.2 Germany DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.6.3 Germany DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.7 France
10.3.2.7.1 France DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.7.2 France DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.7.3 France DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.8 UK
10.3.2.8.1 UK DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.8.2 UK DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.8.3 UK DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.9 Italy
10.3.2.9.1 Italy DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.9.2 Italy DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.9.3 Italy DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.10 Spain
10.3.2.10.1 Spain DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.10.2 Spain DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.10.3 Spain DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.11 Netherlands
10.3.2.11.1 Netherlands DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.11.2 Netherlands DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.11.3 Netherlands DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.12 Switzerland
10.3.2.12.1 Switzerland DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.12.2 Switzerland DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.12.3 Switzerland DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.13 Austria
10.3.2.13.1 Austria DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.13.2 Austria DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.13.3 Austria DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.3.2.14 Rest of Western Europe
10.3.2.14.1 Rest of Western Europe DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.3.2.14.2 Rest of Western Europe DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.3.2.14.3 Rest of Western Europe DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4 Asia Pacific
10.4.1 Trends Analysis
10.4.2 Asia Pacific DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.4.3 Asia Pacific DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.4 Asia Pacific DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.5 Asia Pacific DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.6 China
10.4.6.1 China DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.6.2 China DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.6.3 China DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.7 India
10.4.7.1 India DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.7.2 India DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.7.3 India DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.8 Japan
10.4.8.1 Japan DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.8.2 Japan DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.8.3 Japan DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.9 South Korea
10.4.9.1 South Korea DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.9.2 South Korea DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.9.3 South Korea DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.10 Vietnam
10.4.10.1 Vietnam DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.10.2 Vietnam DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.10.3 Vietnam DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.11 Singapore
10.4.11.1 Singapore DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.11.2 Singapore DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.11.3 Singapore DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.12 Australia
10.4.12.1 Australia DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.12.2 Australia DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.12.3 Australia DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.4.13 Rest of Asia Pacific
10.4.13.1 Rest of Asia Pacific DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.4.13.2 Rest of Asia Pacific DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.4.13.3 Rest of Asia Pacific DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5 Middle East and Africa
10.5.1 Middle East
10.5.1.1 Trends Analysis
10.5.1.2 Middle East DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.1.3 Middle East DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.4 Middle East DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.5 Middle East DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.1.6 UAE
10.5.1.6.1 UAE DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.6.2 UAE DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.6.3 UAE DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.1.7 Egypt
10.5.1.7.1 Egypt DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.7.2 Egypt DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.7.3 Egypt DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.1.8 Saudi Arabia
10.5.1.8.1 Saudi Arabia DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.8.2 Saudi Arabia DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.8.3 Saudi Arabia DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.1.9 Qatar
10.5.1.9.1 Qatar DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.9.2 Qatar DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.9.3 Qatar DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.1.10 Rest of Middle East
10.5.1.10.1 Rest of Middle East DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.1.10.2 Rest of Middle East DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.1.10.3 Rest of Middle East DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.2 Africa
10.5.2.1 Trends Analysis
10.5.2.2 Africa DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.5.2.3 Africa DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.2.4 Africa DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.5 Africa DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.2.6 South Africa
10.5.2.6.1 South Africa DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.2.6.2 South Africa DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.6.3 South Africa DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.2.7 Nigeria
10.5.2.7.1 Nigeria DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.2.7.2 Nigeria DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.7.3 Nigeria DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.5.2.8 Rest of Africa
10.5.2.8.1 Rest of Africa DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.5.2.8.2 Rest of Africa DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.5.2.8.3 Rest of Africa DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.6 Latin America
10.6.1 Trends Analysis
10.6.2 Latin America DNA Synthesis Market Estimates and Forecasts, by Country (2020-2032) (USD Million)
10.6.3 Latin America DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.6.4 Latin America DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.5 Latin America DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.6.6 Brazil
10.6.6.1 Brazil DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.6.6.2 Brazil DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.6.3 Brazil DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.6.7 Argentina
10.6.7.1 Argentina DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.6.7.2 Argentina DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.7.3 Argentina DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.6.8 Colombia
10.6.8.1 Colombia DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.6.8.2 Colombia DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.8.3 Colombia DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
10.6.9 Rest of Latin America
10.6.9.1 Rest of Latin America DNA Synthesis Market Estimates and Forecasts, by Service (2020-2032) (USD Million)
10.6.9.2 Rest of Latin America DNA Synthesis Market Estimates and Forecasts, by Application (2020-2032) (USD Million)
10.6.9.3 Rest of Latin America DNA Synthesis Market Estimates and Forecasts, by End-User (2020-2032) (USD Million)
11. Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Company Overview
11.1.2 Financial
11.1.3 Products/ Services Offered
11.1.4 SWOT Analysis
11.2 Integrated DNA Technologies
11.2.1 Company Overview
11.2.2 Financial
11.2.3 Products/ Services Offered
11.2.4 SWOT Analysis
11.3 BioBasic Inc.
11.3.1 Company Overview
11.3.2 Financial
11.3.3 Products/ Services Offered
11.3.4 SWOT Analysis
11.4 Agilent Technologies
11.4.1 Company Overview
11.4.2 Financial
11.4.3 Products/ Services Offered
11.4.4 SWOT Analysis
11.5 Twist Bioscience
11.5.1 Company Overview
11.5.2 Financial
11.5.3 Products/ Services Offered
11.5.4 SWOT Analysis
11.6 Molecular Assemblies Inc.
11.6.1 Company Overview
11.6.2 Financial
11.6.3 Products/ Services Offered
11.6.4 SWOT Analysis
11.7 Eurofins Genomics
11.7.1 Company Overview
11.7.2 Financial
11.7.3 Products/ Services Offered
11.7.4 SWOT Analysis
11.8 QIAGEN
11.8.1 Company Overview
11.8.2 Financial
11.8.3 Products/ Services Offered
11.8.4 SWOT Analysis
11.9 Genscript Biotech
11.9.1 Company Overview
11.9.2 Financial
11.9.3 Products/ Services Offered
11.9.4 SWOT Analysis
11.10 Genewiz
11.10.1 Company Overview
11.10.2 Financial
11.10.3 Products/ Services Offered
11.10.4 SWOT Analysis
12. Use Cases and Best Practices
13. Conclusion
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Segmentation
By Service
Oligonucleotide Synthesis
Custom Oligonucleotide Synthesis
Pre-designed Oligonucleotide Synthesis
Gene Synthesis
By Application
Research and Development
Therapeutics
Diagnostic
By End-User
Biopharmaceutical Companies
Academic and Research Institutes
Contract Research Organizations
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Healthcare/Medical Simulation Market size was valued at USD 1.81 billion in 2023 is projected grow at a CAGR of 16.31% to reach USD 7.04 billion by 2032.
The global Spatial Omics market, valued at USD 364.30 Million in 2023, is projected to reach USD 842.73 Million by 2032, growing at a compound annual growth rate CAGR of 10.30% during the forecast period.
The Sanger Sequencing Market Size was valued at USD 2,901.15 Million in 2023, and is expected to reach USD 12,356.57 Million by 2032, and grow at a CAGR of 18.63% Over the Forecast Period of 2024-2032.
Breathalyzers Market was valued at USD 2.7 billion in 2023 and is expected to reach USD 10.9 billion by 2032, growing at a CAGR of 16.74% from 2024 to 2032.
The Weight Loss Devices Market Size was valued at USD 5.30 Billion in 2023 and is expected to reach USD 8.50 Billion by 2032 and grow at a CAGR of 6.60% over the forecast period 2024-2032.
The Retinal Surgery Market was valued at USD 2.46 billion in 2023 and is expected to reach USD 4.16 billion by 2032 and grow at a CAGR of 6.05% by 2024-2032
Hi! Click one of our member below to chat on Phone
© 2025 All Rights Reserved by SNS Insider Pvt Ltd
